BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1006 related articles for article (PubMed ID: 24966602)

  • 1. Pathogenesis of liver cirrhosis.
    Zhou WC; Zhang QB; Qiao L
    World J Gastroenterol; 2014 Jun; 20(23):7312-24. PubMed ID: 24966602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.
    Elpek GÖ
    World J Gastroenterol; 2014 Jun; 20(23):7260-76. PubMed ID: 24966597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
    Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
    Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease.
    Katsarou A; Moustakas II; Pyrina I; Lembessis P; Koutsilieris M; Chatzigeorgiou A
    World J Gastroenterol; 2020 May; 26(17):1993-2011. PubMed ID: 32536770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of liver cirrhosis: current evidence and expectations.
    Jung YK; Yim HJ
    Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review).
    Cheng QN; Yang X; Wu JF; Ai WB; Ni YR
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development.
    Ignat SR; Dinescu S; Hermenean A; Costache M
    Cells; 2020 Feb; 9(2):. PubMed ID: 32085494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
    Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc finger protein A20 protects rats against chronic liver allograft dysfunction.
    Yang J; Xu MQ; Yan LN; Chen XB; Liu J
    World J Gastroenterol; 2012 Jul; 18(27):3537-50. PubMed ID: 22826618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk network among multiple inflammatory mediators in liver fibrosis.
    Zhangdi HJ; Su SB; Wang F; Liang ZY; Yan YD; Qin SY; Jiang HX
    World J Gastroenterol; 2019 Sep; 25(33):4835-4849. PubMed ID: 31543677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
    Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
    Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
    Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
    Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression.
    Ma L; Yang X; Wei R; Ye T; Zhou JK; Wen M; Men R; Li P; Dong B; Liu L; Fu X; Xu H; Aqeilan RI; Wei YQ; Yang L; Peng Y
    Cell Death Dis; 2018 Jun; 9(7):718. PubMed ID: 29915227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
    Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
    Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
    [No Abstract]   [Full Text] [Related]  

  • 17. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis.
    Su Q; Kumar V; Sud N; Mahato RI
    Adv Drug Deliv Rev; 2018 Apr; 129():54-63. PubMed ID: 29391222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management strategies for liver fibrosis.
    Altamirano-Barrera A; Barranco-Fragoso B; Méndez-Sánchez N
    Ann Hepatol; 2017; 16(1):48-56. PubMed ID: 28051792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta-like ligand 4/DLL4 regulates the capillarization of liver sinusoidal endothelial cell and liver fibrogenesis.
    Chen L; Gu T; Li B; Li F; Ma Z; Zhang Q; Cai X; Lu L
    Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1663-1675. PubMed ID: 31233801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA interplay between hepatic stellate cell quiescence and activation.
    Ezhilarasan D
    Eur J Pharmacol; 2020 Oct; 885():173507. PubMed ID: 32858048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.